Chemoradiotherapy has emerged as a gold standard in advanced squamous cell carcinoma
of the head and neck (SCCHN). Because 50% of advanced stage patients relapse after …

In the recent years, the prevalence of HPV-positive oropharyngeal squamous cell carcinoma
(OPSCC) has increased significantly. Currently, nearly 80-90% of all oropharynx tumors are …

PURPOSE Reducing radiation treatment dose could improve the quality of life (QOL) of
patients with good-risk human papillomavirus–associated oropharyngeal squamous cell …

Robotics applications in facial plastic surgery has been practical and observed to have
benefits. For instance, minimal invasiveness, small number of incisions, less blood loss …

Opinion statement A larger proportion of patients with head and neck cancers (HNC) are
now surviving, constituting up to 3% of all cancer survivors. This is likely due in part to the …

As the patients population ages, cancer screening increases, and cancer treatments
improve, millions more head and neck carcinoma (HNC) patients will be classified as cancer …

Background Transoral robotic surgery (TORS) is an emerging minimally invasive surgical
treatment for residual, recurrent, and new primary head and neck cancers in previously …

Head and neck cancer is the sixth most common cancer with over 500000 annually reported
incident cases worldwide. Besides major risk factors tobacco and alcohol, oropharyngeal …

The increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) emphasizes
the importance of optimizing treatment for the disease. Historical protocol has utilized …

The practices of head and neck surgical oncologists must evolve to meet the unprecedented
needs placed on our health care system by the Coronavirus disease 2019 (COVID‐19) …